UTMD Relative Valuation
UTMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, UTMD is overvalued; if below, it's undervalued.
Historical Valuation
Utah Medical Products Inc (UTMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Utah Medical Products Inc (UTMD) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：57.70
Fair
0.00
PE
1Y
3Y
5Y
0.00
EV/EBITDA
Utah Medical Products Inc. (UTMD) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Utah Medical Products Inc. (UTMD) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Utah Medical Products Inc. (UTMD) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Utah Medical Products Inc. (UTMD) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Utah Medical Products Inc. (UTMD) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Utah Medical Products Inc (UTMD) has a current Price-to-Book (P/B) ratio of 1.53. Compared to its 3-year average P/B ratio of 2.09 , the current P/B ratio is approximately -26.73% higher. Relative to its 5-year average P/B ratio of 2.48, the current P/B ratio is about -38.36% higher. Utah Medical Products Inc (UTMD) has a Forward Free Cash Flow (FCF) yield of approximately 7.67%. Compared to its 3-year average FCF yield of 6.83%, the current FCF yield is approximately 12.31% lower. Relative to its 5-year average FCF yield of 6.55% , the current FCF yield is about 17.02% lower.
1.53
P/B
Median3y
2.09
Median5y
2.48
7.67
FCF Yield
Median3y
6.83
Median5y
6.55
Competitors Valuation Multiple
The average P/S ratio for UTMD's competitors is 88.01, providing a benchmark for relative valuation. Utah Medical Products Inc Corp (UTMD) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of -1.93%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of UTMD decreased by 6.52% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 13.31 to 15.98.
The secondary factor is the Revenue Growth, contributed -1.93%to the performance.
Overall, the performance of UTMD in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
AZ
A2Z Cust2Mate Solutions Corp
8.04USD
3.08%
JRVR
James River Group Holdings Inc
6.21USD
0.98%
APPS
Digital Turbine Inc
5.14USD
0.78%
CIO
City Office REIT Inc
7USD
0.00%
SJT
San Juan Basin Royalty Trust
5.64USD
0.53%
SOPH
SOPHiA GENETICS SA
5USD
4.17%
ESCA
Escalade Inc
14.09USD
0.64%
HWBK
Hawthorn Bancshares Inc
31.92USD
-4.66%
AEYE
AudioEye Inc
9.64USD
-1.33%
GROY
Gold Royalty Corp
4.43USD
1.84%
Frequently Asked Questions
Is Utah Medical Products Inc (UTMD) currently overvalued or undervalued?
Utah Medical Products Inc (UTMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Utah Medical Products Inc (UTMD) is between to according to relative valuation methord.
What is Utah Medical Products Inc (UTMD) fair value?
UTMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Utah Medical Products Inc (UTMD) is between to according to relative valuation methord.
How does UTMD's valuation metrics compare to the industry average?
The average P/S ratio for UTMD's competitors is 88.01, providing a benchmark for relative valuation. Utah Medical Products Inc Corp (UTMD) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -1.93%, this premium appears unsustainable.
What is the current P/B ratio for Utah Medical Products Inc (UTMD) as of Jan 08 2026?
As of Jan 08 2026, Utah Medical Products Inc (UTMD) has a P/B ratio of 1.53. This indicates that the market values UTMD at 1.53 times its book value.
What is the current FCF Yield for Utah Medical Products Inc (UTMD) as of Jan 08 2026?
As of Jan 08 2026, Utah Medical Products Inc (UTMD) has a FCF Yield of 7.67%. This means that for every dollar of Utah Medical Products Inc’s market capitalization, the company generates 7.67 cents in free cash flow.
What is the current Forward P/E ratio for Utah Medical Products Inc (UTMD) as of Jan 08 2026?
As of Jan 08 2026, Utah Medical Products Inc (UTMD) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Utah Medical Products Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Utah Medical Products Inc (UTMD) as of Jan 08 2026?
As of Jan 08 2026, Utah Medical Products Inc (UTMD) has a Forward P/S ratio of 0.00. This means the market is valuing UTMD at $0.00 for every dollar of expected revenue over the next 12 months.